1.
Braz. j. infect. dis
; Braz. j. infect. dis;20(4): 401-402, July-Aug. 2016. graf
Article
in English
| LILACS
| ID: biblio-828130
Subject(s)
Humans , HIV Infections/drug therapy , HIV Protease Inhibitors/administration & dosage , Ritonavir/administration & dosage , HIV-Associated Lipodystrophy Syndrome/chemically induced , Darunavir/administration & dosage , Triglycerides/blood , Prospective Studies , HIV Protease Inhibitors/adverse effects , Ritonavir/adverse effects , HIV-Associated Lipodystrophy Syndrome/blood , Drug Substitution , Darunavir/adverse effects , Cholesterol, LDL/blood
2.
Braz J Infect Dis
; 20(4): 401-2, 2016.
Article
in English
| MEDLINE
| ID: mdl-26971833
Subject(s)
Darunavir/administration & dosage , HIV Infections/drug therapy , HIV Protease Inhibitors/administration & dosage , HIV-Associated Lipodystrophy Syndrome/chemically induced , Ritonavir/administration & dosage , Cholesterol, LDL/blood , Darunavir/adverse effects , Drug Substitution , HIV Protease Inhibitors/adverse effects , HIV-Associated Lipodystrophy Syndrome/blood , Humans , Prospective Studies , Ritonavir/adverse effects , Triglycerides/blood
3.
Braz J Infect Dis
; 19(6): 668-9, 2015.
Article
in English
| MEDLINE
| ID: mdl-26477384